肿瘤细胞治疗研究
MODALITY HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性，以登记原文和主治医生判断为准。
FOR RESEARCH
Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunothera
本研究描述了通过植入组织切片构建新型原位 PDAC 模型，并从 PDAC 微环境的角度探讨了免疫治疗耐药。
Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer.
嵌合抗原受体（CAR）-T 细胞在治疗实体瘤时面临诸多问题，包括肿瘤抗原异质性和免疫抑制。
MEMBER ACCOUNT
登录成功会直接打开下一页。
